Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification

Autores: Ghelfi, Albertina M.; Staffieri, Gustavo J.; Del Sueldo, Mildren A.; Miranda, Gonzalo; Renna, Nicolas Federico; Quintana, Rosana Maris; Lassus, Melisa N.; Galván, María Rosa; Maldonado, Romina; Passarino, Flavia A.; Fierro, Lautaro N.; Velez, Lautaro L.; Graziani, Laura; Kisluk, Boris; Berbotto, Leonel A.; Nieto, Romina; Mamprin D´andrea, Rubén F.; Berbotto, Guillermo A.; Galindez, Jorge O.
Año de publicación: 2025
Idioma: inglés
Tipo de recurso: artículo
Estado: versión publicada
Descripción: Objectives Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular disease. AS can be determined by carotid-femoral pulse wave velocity (cf-PWV). In women with low-CVR and a CVRE, our objective was to determine cf-PWV values and AS, and to compare with a control group. Material and Methods Multicentric cross-sectional study, from 2022 to 2024 in Argentina. Included women between 18 and 59 years-old, without traditional CVR-factors, low (<5 %) 10-year CVR, and office blood-pressure (BP) <140/90 mmHg. Inclusion criteria: Group 1: presence of a CVRE (history of gestational hypertension, preeclampsia; autoimmune rheumatic or hematological disease in clinical remission; previous oncological treatment in current complete remission; history of abortions; early menopause or menarche; anxiety or depression disorder; human immunodeficiency virus infected virally suppressed). Group-2: women who attended routine control. Exclusion criteria: hypertension; diabetes; target organ damage; chronic kidney disease; current smoking; history of CV-event; statins, aspirin, or antihypertensive treatment. Results Included 280 women: Group-1 (N = 174); Group-2 (N = 106). Group-1 showed higher cf-PWV: 7.02±1.20 vs. 5.71±0.86 (p < 0.0001) and higher AS frequency: 52.9 % vs. 0.9 % (p < 0.0001). A sub-analysis performed in the 199 women with office-BP <130/85 mmHg and central (aortic) systolic-BP was <121 mmHg also showed higher cf-PWV 6.70±1.07 vs. 5.62±0.78 (p < 0.0001) and higher AS: 43.4 % vs. 0.0 % (p < 0.0001) in Group-1. cf-PWV values maintain related with CVRE presence (p < 0.0001) at multivariate analysis. Conclusions Women with CVRE showed greater cf-PWV and higher frequency of AS.
Fil: Ghelfi, Albertina M.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina. Sociedad Argentina de Hipertensión Arterial; Argentina
Fil: Staffieri, Gustavo J.. Sociedad Argentina de Hipertensión Arterial; Argentina. Grupo Oroño; Argentina
Fil: Del Sueldo, Mildren A.. Sociedad Argentina de Hipertensión Arterial; Argentina. Centro de Salud y Rehabilitación Cardiovascular; Argentina
Fil: Miranda, Gonzalo. Sociedad Argentina de Hipertensión Arterial; Argentina. Centro de Salud y Rehabilitación Cardiovascular; Argentina
Fil: Renna, Nicolas Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Gobierno de la Provincia de Mendoza. Hospital Español de Mendoza; . Sociedad Argentina de Hipertensión Arterial; Argentina
Fil: Quintana, Rosana Maris. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Lassus, Melisa N.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Galván, María Rosa. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Maldonado, Romina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Passarino, Flavia A.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Fierro, Lautaro N.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Velez, Lautaro L.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Graziani, Laura. Gobierno de la Provincia de Mendoza. Hospital Español de Mendoza;
Fil: Kisluk, Boris. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Berbotto, Leonel A.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Nieto, Romina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Mamprin D´andrea, Rubén F.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Berbotto, Guillermo A.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Fil: Galindez, Jorge O.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
Materia: Cardiovascular risk
Women’s health
Hypertension
Nivel de accesibilidad: acceso abierto
Condiciones de uso: https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
Institución: Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador: oai:ri.conicet.gov.ar:11336/291754

Acceder

id	CONICETDig_40f9c352a7e444e27122eccf6ee7690c
oai_identifier_str	oai:ri.conicet.gov.ar:11336/291754
network_acronym_str	CONICETDig
repository_id_str	3498
network_name_str	CONICET Digital (CONICET)
spelling	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratificationGhelfi, Albertina M.Staffieri, Gustavo J.Del Sueldo, Mildren A.Miranda, GonzaloRenna, Nicolas FedericoQuintana, Rosana MarisLassus, Melisa N.Galván, María RosaMaldonado, RominaPassarino, Flavia A.Fierro, Lautaro N.Velez, Lautaro L.Graziani, LauraKisluk, BorisBerbotto, Leonel A.Nieto, RominaMamprin D´andrea, Rubén F.Berbotto, Guillermo A.Galindez, Jorge O.Cardiovascular riskWomen’s healthHypertensionhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Objectives Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular disease. AS can be determined by carotid-femoral pulse wave velocity (cf-PWV). In women with low-CVR and a CVRE, our objective was to determine cf-PWV values and AS, and to compare with a control group. Material and Methods Multicentric cross-sectional study, from 2022 to 2024 in Argentina. Included women between 18 and 59 years-old, without traditional CVR-factors, low (<5 %) 10-year CVR, and office blood-pressure (BP) <140/90 mmHg. Inclusion criteria: Group 1: presence of a CVRE (history of gestational hypertension, preeclampsia; autoimmune rheumatic or hematological disease in clinical remission; previous oncological treatment in current complete remission; history of abortions; early menopause or menarche; anxiety or depression disorder; human immunodeficiency virus infected virally suppressed). Group-2: women who attended routine control. Exclusion criteria: hypertension; diabetes; target organ damage; chronic kidney disease; current smoking; history of CV-event; statins, aspirin, or antihypertensive treatment. Results Included 280 women: Group-1 (N = 174); Group-2 (N = 106). Group-1 showed higher cf-PWV: 7.02±1.20 vs. 5.71±0.86 (p < 0.0001) and higher AS frequency: 52.9 % vs. 0.9 % (p < 0.0001). A sub-analysis performed in the 199 women with office-BP <130/85 mmHg and central (aortic) systolic-BP was <121 mmHg also showed higher cf-PWV 6.70±1.07 vs. 5.62±0.78 (p < 0.0001) and higher AS: 43.4 % vs. 0.0 % (p < 0.0001) in Group-1. cf-PWV values maintain related with CVRE presence (p < 0.0001) at multivariate analysis. Conclusions Women with CVRE showed greater cf-PWV and higher frequency of AS.Fil: Ghelfi, Albertina M.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina. Sociedad Argentina de Hipertensión Arterial; ArgentinaFil: Staffieri, Gustavo J.. Sociedad Argentina de Hipertensión Arterial; Argentina. Grupo Oroño; ArgentinaFil: Del Sueldo, Mildren A.. Sociedad Argentina de Hipertensión Arterial; Argentina. Centro de Salud y Rehabilitación Cardiovascular; ArgentinaFil: Miranda, Gonzalo. Sociedad Argentina de Hipertensión Arterial; Argentina. Centro de Salud y Rehabilitación Cardiovascular; ArgentinaFil: Renna, Nicolas Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Gobierno de la Provincia de Mendoza. Hospital Español de Mendoza; . Sociedad Argentina de Hipertensión Arterial; ArgentinaFil: Quintana, Rosana Maris. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Lassus, Melisa N.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Galván, María Rosa. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Maldonado, Romina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Passarino, Flavia A.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Fierro, Lautaro N.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Velez, Lautaro L.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Graziani, Laura. Gobierno de la Provincia de Mendoza. Hospital Español de Mendoza;Fil: Kisluk, Boris. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Berbotto, Leonel A.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Nieto, Romina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Mamprin D´andrea, Rubén F.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Berbotto, Guillermo A.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaFil: Galindez, Jorge O.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; ArgentinaElsevier2025-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/291754Ghelfi, Albertina M.; Staffieri, Gustavo J.; Del Sueldo, Mildren A.; Miranda, Gonzalo; Renna, Nicolas Federico; et al.; Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification; Elsevier; American Journal of Preventive Cardiology; 21; 3-2025; 1-92666-6677CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S2666667725000157info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajpc.2025.100942info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-08-25T14:53:05Zoai:ri.conicet.gov.ar:11336/291754instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-08-25 14:53:05.36CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
title	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
spellingShingle	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification Ghelfi, Albertina M. Cardiovascular risk Women’s health Hypertension
title_short	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
title_full	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
title_fullStr	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
title_full_unstemmed	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
title_sort	Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification
dc.creator.none.fl_str_mv	Ghelfi, Albertina M. Staffieri, Gustavo J. Del Sueldo, Mildren A. Miranda, Gonzalo Renna, Nicolas Federico Quintana, Rosana Maris Lassus, Melisa N. Galván, María Rosa Maldonado, Romina Passarino, Flavia A. Fierro, Lautaro N. Velez, Lautaro L. Graziani, Laura Kisluk, Boris Berbotto, Leonel A. Nieto, Romina Mamprin D´andrea, Rubén F. Berbotto, Guillermo A. Galindez, Jorge O.
author	Ghelfi, Albertina M.
author_facet	Ghelfi, Albertina M. Staffieri, Gustavo J. Del Sueldo, Mildren A. Miranda, Gonzalo Renna, Nicolas Federico Quintana, Rosana Maris Lassus, Melisa N. Galván, María Rosa Maldonado, Romina Passarino, Flavia A. Fierro, Lautaro N. Velez, Lautaro L. Graziani, Laura Kisluk, Boris Berbotto, Leonel A. Nieto, Romina Mamprin D´andrea, Rubén F. Berbotto, Guillermo A. Galindez, Jorge O.
author_role	author
author2	Staffieri, Gustavo J. Del Sueldo, Mildren A. Miranda, Gonzalo Renna, Nicolas Federico Quintana, Rosana Maris Lassus, Melisa N. Galván, María Rosa Maldonado, Romina Passarino, Flavia A. Fierro, Lautaro N. Velez, Lautaro L. Graziani, Laura Kisluk, Boris Berbotto, Leonel A. Nieto, Romina Mamprin D´andrea, Rubén F. Berbotto, Guillermo A. Galindez, Jorge O.
author2_role	author author author author author author author author author author author author author author author author author author
dc.subject.none.fl_str_mv	Cardiovascular risk Women’s health Hypertension
topic	Cardiovascular risk Women’s health Hypertension
purl_subject.fl_str_mv	https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv	Objectives Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular disease. AS can be determined by carotid-femoral pulse wave velocity (cf-PWV). In women with low-CVR and a CVRE, our objective was to determine cf-PWV values and AS, and to compare with a control group. Material and Methods Multicentric cross-sectional study, from 2022 to 2024 in Argentina. Included women between 18 and 59 years-old, without traditional CVR-factors, low (<5 %) 10-year CVR, and office blood-pressure (BP) <140/90 mmHg. Inclusion criteria: Group 1: presence of a CVRE (history of gestational hypertension, preeclampsia; autoimmune rheumatic or hematological disease in clinical remission; previous oncological treatment in current complete remission; history of abortions; early menopause or menarche; anxiety or depression disorder; human immunodeficiency virus infected virally suppressed). Group-2: women who attended routine control. Exclusion criteria: hypertension; diabetes; target organ damage; chronic kidney disease; current smoking; history of CV-event; statins, aspirin, or antihypertensive treatment. Results Included 280 women: Group-1 (N = 174); Group-2 (N = 106). Group-1 showed higher cf-PWV: 7.02±1.20 vs. 5.71±0.86 (p < 0.0001) and higher AS frequency: 52.9 % vs. 0.9 % (p < 0.0001). A sub-analysis performed in the 199 women with office-BP <130/85 mmHg and central (aortic) systolic-BP was <121 mmHg also showed higher cf-PWV 6.70±1.07 vs. 5.62±0.78 (p < 0.0001) and higher AS: 43.4 % vs. 0.0 % (p < 0.0001) in Group-1. cf-PWV values maintain related with CVRE presence (p < 0.0001) at multivariate analysis. Conclusions Women with CVRE showed greater cf-PWV and higher frequency of AS. Fil: Ghelfi, Albertina M.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina. Sociedad Argentina de Hipertensión Arterial; Argentina Fil: Staffieri, Gustavo J.. Sociedad Argentina de Hipertensión Arterial; Argentina. Grupo Oroño; Argentina Fil: Del Sueldo, Mildren A.. Sociedad Argentina de Hipertensión Arterial; Argentina. Centro de Salud y Rehabilitación Cardiovascular; Argentina Fil: Miranda, Gonzalo. Sociedad Argentina de Hipertensión Arterial; Argentina. Centro de Salud y Rehabilitación Cardiovascular; Argentina Fil: Renna, Nicolas Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Gobierno de la Provincia de Mendoza. Hospital Español de Mendoza; . Sociedad Argentina de Hipertensión Arterial; Argentina Fil: Quintana, Rosana Maris. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Lassus, Melisa N.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Galván, María Rosa. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Maldonado, Romina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Passarino, Flavia A.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Fierro, Lautaro N.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Velez, Lautaro L.. Universidad Abierta Interamericana. Facultad de Medicina; Argentina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Graziani, Laura. Gobierno de la Provincia de Mendoza. Hospital Español de Mendoza; Fil: Kisluk, Boris. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Berbotto, Leonel A.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Nieto, Romina. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Mamprin D´andrea, Rubén F.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Berbotto, Guillermo A.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina Fil: Galindez, Jorge O.. Gobierno de la Provincia de Santa Fe. Hospital Escuela Eva Peron; Argentina
description	Objectives Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular disease. AS can be determined by carotid-femoral pulse wave velocity (cf-PWV). In women with low-CVR and a CVRE, our objective was to determine cf-PWV values and AS, and to compare with a control group. Material and Methods Multicentric cross-sectional study, from 2022 to 2024 in Argentina. Included women between 18 and 59 years-old, without traditional CVR-factors, low (<5 %) 10-year CVR, and office blood-pressure (BP) <140/90 mmHg. Inclusion criteria: Group 1: presence of a CVRE (history of gestational hypertension, preeclampsia; autoimmune rheumatic or hematological disease in clinical remission; previous oncological treatment in current complete remission; history of abortions; early menopause or menarche; anxiety or depression disorder; human immunodeficiency virus infected virally suppressed). Group-2: women who attended routine control. Exclusion criteria: hypertension; diabetes; target organ damage; chronic kidney disease; current smoking; history of CV-event; statins, aspirin, or antihypertensive treatment. Results Included 280 women: Group-1 (N = 174); Group-2 (N = 106). Group-1 showed higher cf-PWV: 7.02±1.20 vs. 5.71±0.86 (p < 0.0001) and higher AS frequency: 52.9 % vs. 0.9 % (p < 0.0001). A sub-analysis performed in the 199 women with office-BP <130/85 mmHg and central (aortic) systolic-BP was <121 mmHg also showed higher cf-PWV 6.70±1.07 vs. 5.62±0.78 (p < 0.0001) and higher AS: 43.4 % vs. 0.0 % (p < 0.0001) in Group-1. cf-PWV values maintain related with CVRE presence (p < 0.0001) at multivariate analysis. Conclusions Women with CVRE showed greater cf-PWV and higher frequency of AS.
publishDate	2025
dc.date.none.fl_str_mv	2025-03
dc.type.none.fl_str_mv	info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo
format	article
status_str	publishedVersion
dc.identifier.none.fl_str_mv	http://hdl.handle.net/11336/291754 Ghelfi, Albertina M.; Staffieri, Gustavo J.; Del Sueldo, Mildren A.; Miranda, Gonzalo; Renna, Nicolas Federico; et al.; Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification; Elsevier; American Journal of Preventive Cardiology; 21; 3-2025; 1-9 2666-6677 CONICET Digital CONICET
url	http://hdl.handle.net/11336/291754
identifier_str_mv	Ghelfi, Albertina M.; Staffieri, Gustavo J.; Del Sueldo, Mildren A.; Miranda, Gonzalo; Renna, Nicolas Federico; et al.; Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification; Elsevier; American Journal of Preventive Cardiology; 21; 3-2025; 1-9 2666-6677 CONICET Digital CONICET
dc.language.none.fl_str_mv	eng
language	eng
dc.relation.none.fl_str_mv	info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S2666667725000157 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajpc.2025.100942
dc.rights.none.fl_str_mv	info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv	openAccess
rights_invalid_str_mv	https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv	application/pdf application/pdf
dc.publisher.none.fl_str_mv	Elsevier
publisher.none.fl_str_mv	Elsevier
dc.source.none.fl_str_mv	reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str	CONICET Digital (CONICET)
collection	CONICET Digital (CONICET)
instname_str	Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv	CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv	dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_	1874774826970775552
score	13.24418

Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification

Publicaciones similares